Gene-environment interactions resulting in risk alcohol drinking behaviour are mediated by CRF and CRF1

Pharmacology Biochemistry and Behavior

Volumn 93, Issue 3, 2009, Pages 230-236

  Clarke, Toni Kim ^a   Schumann, Gunter ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Alcoholism; CRF; CRF1; HPA axis; Noradrenaline; Norepinephrine; Stress; Substance abuse

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1;

ALCOHOLISM; AMYGDALOID NUCLEUS; ENVIRONMENTAL FACTOR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HORMONE ACTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROBIOLOGY; NONHUMAN; NORADRENERGIC SYSTEM; PHARMACOGENETICS; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBSTANCE ABUSE;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DISEASE MODELS, ANIMAL; ENVIRONMENT; HUMANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RISK-TAKING; STRESS, PSYCHOLOGICAL;

ANIMALIA;

EID: 67649447369     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2009.04.014     Document Type: Review

References (83)

1. Abelson J.L., Liberzon I., Young E.A., and Khan S. Cognitive modulation of the endocrine stress response to a pharmacological challenge in normal and panic disorder subjects. Arch Gen Psychiatry 62 (2005) 668-675
2. Amit Z., Levitan D.E., and Lindros K.O. Suppression of ethanol intake following administration of dopamine-beta-hydroxylase inhibitors in rats. Arch Int Pharmacodyn Ther 230 (1976) 65-75
3. Bale T.L., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24 (2000) 410-414
4. Berridge C.W., and Waterhouse B.D. The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42 (2003) 33-84
5. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev (2001) 73-86 2-5-
6. Blomeyer D, et al. Interaction between CRHR1 and stressful life events predicts adolescent heavy alcohol use. Submitted (submitted for publication).
7. Britton K.T., Lee G., Dana R., Risch S.C., and Koob G.F. Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci 39 (1986) 1281-1286 6-10-
8. Camron O.G. Anxious-depressive comorbidity: effects on HPA axis and CNS noradrenergic function. Essent Psychopharmocol 7 (2006) 24-34
9. Chen R., Lewis K.A., Perrin M.H., and Vale W.W. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci U S A 90 (1993) 8967-8971 1-10-
10. Chu K., Koob G.F., Cole M., Zorrilla E.P., and Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol Biochem Behav 86 (2007) 813-821
11. Commons K.G., Connolley K.R., and Valentino R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology 28 (2003) 206-215
12. Cummings S., Elde R., Ells J., and Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3 (1983) 1355-1368
13. Cummings S., Elde R., Ells J., and Lindall A. Corticotropin-releasing factor immunoreactivity is widely distributed within the central nervous system of the rat: an immunohistochemical study. J Neurosci 3 (1983) 1355-1368
14. Curtis A.L., Bello N.T., Connolly K.R., and Valentino R.J. Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J Neuroendocrinol 14 (2002) 667-682
15. Curtis A.L., Bello N.T., Connolly K.R., and Valentino R.J. Corticotropin-releasing factor neurones of the central nucleus of the amygdala mediate locus coeruleus activation by cardiovascular stress. J Neuroendocrinol 14 (2002) 667-682
16. DeRijk RH, Wüst S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman FG, de Kloet ER. A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. J Clin Endocrinol Metab 2006 Dec;91(12):5083-9.
17. de Waele J.P., and Gianoulakis C. Effects of single and repeated exposures to ethanol on hypothalamic beta-endorphin and CRH release by the C57BL/6 and DBA/2 strains of mice. Neuroendocrinology 57 (1993) 700-709
18. Deminiere J.M., et al. Increased locomotor response to novelty and propensity to intravenous amphetamine self-administration in adult offspring of stressed mothers. Brain Res 586 (1992) 135-139 17-7-
19. Eaves M., Thatcher-Britton K., Rivier J., Vale W., and Koob G.F. Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats. Peptides 6 (1985) 923-926
20. Finley JC Jr, O'Leary M, Wester D, MacKenzie S, Shepard N, Farrow S, Lockette W. A genetic polymorphism of the alpha2-adrenergic receptor increases autonomic responses to stress. J Appl Physiol 2004 Jun;96(6):2231-9.
21. Fung MM, Nguyen C, Mehtani P, Salem RM, Perez B, Thomas B, Das M, Schork NJ, Mahata SK, Ziegler MG, O'Connor DT. Genetic variation within adrenergic pathways determines in vivo effects of presynaptic stimulation in humans. Circulation 2008 Jan 29;117(4):517-25.
22. Funk C.K., O Dell L.E., Crawford E.F., and Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J Neurosci 26 (2006) 11324-11332
23. Gilpin N.W., Richardson H.N., and Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol Clin Exp Res 32 (2008) 1535-1542
24. Gray T.S., and Bingaman E.W. The amygdala: corticotropin-releasing factor, steroids, and stress. Crit Rev Neurobiol 10 (1996) 155-168
25. Haefner S., Baghai TC., Schule C., Eser D., Spraul M., Zill P., Rupprecht R., and Bondy B. Impact of gene-gender effects of adrenergic polymorphisms on hypothalamic-pituitary-adrenal axis activity in depressed patients. Neuropsychobiology 58 3-4 (2008) 154-162
26. Hansson A.C., et al. Variation at the rat CRHR1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 103 (2006) 15236-15241
27. Hansson A.C., Cippitelli A., Sommer W.H., Ciccocioppo R., and Heilig M. Region-specific down-regulation of CRHR1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict Biol 12 (2007) 30-34
28. Hawley R.J., Major L.F., Schulman E.A., and Linnoila M. Cerebrospinal fluid 3-methoxy-4-hydroxyphenylglycol and norepinephrine levels in alcohol withdrawal. Correlations with clinical signs. Arch Gen Psychiatry 42 (1985) 1056-1062
29. Heilig M., and Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30 (2007) 399-406
30. Henikoff S., Furuyama T., and Ahmad K. Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20 (2004) 320-326
31. Huizink A.C., Ferdinand R.F., Ormel J., and Verhulst F.C. Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 101 (2006) 1581-1588
32. Ising M., Depping A.M., Siebertz A., Lucae S., Unschuld P.G., Kloiber S., Hormstmann S., Uhr M., Müller-Myhsok B., and Holsboer F. Polymorphisms in the FKBP5 gene region modulate recovery from psychosocial stress in healthy controls. Eur J Neurosci 28 2 (2008 Jul) 389-398
33. Junghanns K., et al. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 40 (2005) 80-85
34. Junghanns K., Horbach R., Ehrenthal D., Blank S., and Backhaus J. Cortisol awakening response in abstinent alcohol-dependent patients as a marker of HPA-axis dysfunction. Psychoneuroendocrinology 32 (2007) 1133-1137
35. Kirschbaum C., Wüst S., Faig H.G., and Hellhammer D.H. Heritability of cortisol responses to human corticotropin-releasing hormone, ergometry, and psychological stress in humans. J Clin Endocrinol Metab 75 (1992) 1526-1530
36. Koob G.F. A role for brain stress systems in addiction. Neuron 59 (2008) 11-34 10-7-
37. Koob G.F. Alcoholism, corticotropin-releasing factor, and molecular genetic allostasis. Biol Psychiatry 63 (2008) 137-138 15-1-
38. Koob G.F., and Le Moal M. Addiction and the brain anti reward system. Ann Rev Psychol 59 (2008) 29-53
39. Korf J., Aghajanian G.K., and Roth R.H. Increased turnover of norepinephrine in the rat cerebral cortex during stress: role of the locus coeruleus. Neuropharmacology 12 (1973) 933-938
40. Kreek M.J., et al. ACTH, cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neuropeptides 5 (1984) 277-278
41. Le A.D., Harding S., Juzytsch W., Funk D., and Shaham Y. Role of alpha-2 adrenoceptors in stress-induced reinstatement of alcohol seeking and alcohol self-administration in rats. Pschophamacology (Berlin) 176 (2005) 366-373
42. Linkowski P., et al. Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 264 (1993) E173-E181
43. Lovenberg T.W., et al. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci U S A 92 (1995) 836-840 31-1-
44. Makino S., Gold P.W., and Schulkin J. Corticosterone effects on corticotropin-releasing hormone mRNA in the central nucleus of the amygdala and the parvocellular region of the paraventricular nucleus of the hypothalamus. Brain Res 640 (1994) 105-112 21-3-
45. Makino S., Gold P.W., and Schulkin J. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus. Brain Res 657 (1994) 141-149 19-9-
46. Makino S., Hashimoto K., and Gold P.W. Multiple feedback mechanisms activating corticotropin-releasing hormone system in the brain during stress. Pharmacol Biochem Behav 73 (2002) 147-158
47. Marinelli P.W., et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl) 195 (2007) 345-355
48. Meikle A.W., Stringham J.D., Woodward M.G., and Bishop D.T. Heritability of variation of plasma cortisol levels. Metabolism 37 (1988) 514-517
49. Menzaghi F., Heinrichs S.C., Merlo-Pich E., Tilders F.J., and Koob G.F. Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats. Neurosci Lett 168 (1994) 139-142 28-2-
50. Merchenthaler I., Vigh S., Petrusz P., and Schally A.V. Immunocytochemical localization of corticotropin-releasing factor (CRF) in the rat brain. Am J Anat 165 (1982) 385-396
51. Ogilvie K., Lee S., and Rivier C. Effect of three different modes of alcohol administration on the activity of the rat hypothalamic-pituitary-adrenal axis. Alcohol Clin Exp Res 21 (1997) 467-476
52. Panarelli M, Holloway CD, Fraser R, Connell JM, Ingram MC, Anderson NH, Kenyon CJ. Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J Clin Endocrinol Metab 1998 Jun;83:1846-52.
53. Pandey S.C., Ugale R., Zhang H., Tang L., and Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. J Neurosci 28 (2008) 3729-3737 2-4-
54. Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, Rana BK, Das M, Rodriguez-Flores JL, Smith DW, Cadman PE, Salem RM, Mahata SK, Schork NJ, Taupenot L, Ziegler MG, O'Connor DT. Adrenergic polymorphism and the human stress response. Ann N Y Acad Sci 2008 Dec;1148:282-96.
55. Razin A. CpG methylation, chromatin structure and gene silencing-a three-way connection. EMBO J 17 (1998) 4905-4908 1-9-
56. Rivier C., Rivier J., and Lee S. Importance of pituitary and brain receptors for corticotrophin-releasing factor in modulating alcohol-induced ACTH secretion in the rat. Brain Res 721 (1996) 83-90 20-5-
57. Robbins T.W., et al. Neural systems underlying arousal and attention. Implications for drug abuse. Ann N Y Acad Sci 846 (1998) 222-237 21-6-
58. Russcher H, Smit P, van den Akker EL, van Rossum EF, Brinkmann AO, de Jong FH, Lamberts SW, Koper JW. Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression. J Clin Endocrinol Metab 2005 Oct;90(10)5804-10.
59. Sabino V., et al. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berl) 189 (2006) 175-186
60. Sarnyai Z., Shaham Y., and Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacol Rev 53 (2001) 209-243
61. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychophamacology 158 (2001) 343-359
62. Sinha R., et al. Hypothalamic-pituitary-adrenal axis and sympatho-adreno-medullary responses during stress-induced and drug cue-induced cocaine craving states. Psychopharmacology (Berl) 170 (2003) 62-72
63. Sinha R., Garcia M., Paliwal P., Kreek M.J., and Rounsaville B.J. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63 (2006) 324-331
64. Smith G.W., et al. Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development. Neuron 20 (1998) 1093-1102
65. Sommer W.H., et al. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala CRHR1 expression following a history of dependence. Biol Psychiatry 63 (2008) 139-145 15-1-
66. Stenzel-Poore M.P., Cameron V.A., Vaughan J., Sawchenko P.E., and Vale W. Development of Cushing's syndrome in corticotropin-releasing factor transgenic mice. Endocrinology 130 (1992) 3378-3386
67. Stevens A, Ray DW, Zeggini E, John S, Richards HL, Griffiths CE, Donn R. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endocrinol Metab 2004 Feb;89:892-7.
68. Szyf M., Weaver I., and Meaney M. Maternal care, the epigenome and phenotypic differences in behavior. Reprod Toxicol 24 (2007) 9-19
69. Takahashi L.K., Ho S.P., Livanov V., Graciani N., and Arneric S.P. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res 902 (2001) 135-142 1-6-
70. Treutlein J., et al. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol Psychiatry 11 (2006) 594-602
71. Tsigos C., and Chrousos G.P. Physiology of the hypothalamic-pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metab Clin North Am 23 (1994) 451-466
72. Valdez G.R., Zorrilla E.P., Roberts A.J., and Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 29 (2003) 55-60
73. Valentino R.J., and Wehby R.G. Corticotropin-releasing factor: evidence for a neurotransmitter role in the locus ceruleus during hemodynamic stress. Neuroendocrinology 48 (1988) 674-677
74. Valentino R.J., Page M.E., and Curtis A.L. Activation of noradrenergic locus coeruleus neurons by hemodynamic stress is due to local release of corticotropin-releasing factor. Brain Res 555 (1991) 25-34 26-7-
75. Valentino R.J., Foote S.L., and Page M.E. The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci 697 (1993) 173-188 29-10-
76. Van P.K., et al. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428 (2000) 191-212 11-12-
77. van Rossum EF, Lamberts SW. Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog Horm Res 2004;59:333-57.
78. Weaver I.C., et al. Epigenetic programming by maternal behavior. Nat Neurosci 7 (2004) 847-854
79. Wüst S., Federenko I., Hellhammer D.H., and Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology 25 (2000) 707-720
80. Wüst S, Van Rossum EF, Federenko IS, Koper JW, Kumsta R, Hellhammer DH. Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J Clin Endocrinol Metab 2004 Feb;89(2):565-73.
81. Yang X., Wang S., Rice K.C., Munro C.A., and Wand G.S. Restraint stress and ethanol consumption in two mouse strains. Alcohol Clin Exp Res 32 (2008) 840-852
82. Zimmermann U., et al. Effect of ethanol on hypothalamic-pituitary-adrenal system response to psychosocial stress in sons of alcohol-dependent fathers. Neuropsychopharmacology 29 (2004) 1156-1165
83. Zorrilla E.P., and Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin Investig Drugs 13 (2004) 799-828